These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 8723468)
1. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Doern GV; Brueggemann A; Holley HP; Rauch AM Antimicrob Agents Chemother; 1996 May; 40(5):1208-13. PubMed ID: 8723468 [TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Doern GV; Brueggemann AB; Pierce G; Holley HP; Rauch A Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182 [TBL] [Abstract][Full Text] [Related]
3. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study. Jacobs MR; Bajaksouzian S; Zilles A; Lin G; Pankuch GA; Appelbaum PC Antimicrob Agents Chemother; 1999 Aug; 43(8):1901-8. PubMed ID: 10428910 [TBL] [Abstract][Full Text] [Related]
4. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents. Peric M; Browne FA; Jacobs MR; Appelbaum PC Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118 [TBL] [Abstract][Full Text] [Related]
5. Surveillance of pneumococcal resistance in Belgium during winter 1996-1997. Vanhoof R; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Mans Y; Nyssen HJ; Simon A; Surmont I; Van De Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R Acta Clin Belg; 1998 Aug; 53(4):275-81. PubMed ID: 9795449 [TBL] [Abstract][Full Text] [Related]
6. Surveillance of antibiotic resistance in clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2000-2001. Vanhoof R; Carpentier M; Cartuyvels R; Damée S; Fagnart O; Garrino MG; Glupczynski Y; Gordts B; Govaerts D; Magerman K; Mans I; Surmont I; Van Bossuyt E; Van De Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R Acta Clin Belg; 2003; 58(2):111-9. PubMed ID: 12836494 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin. Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Gimeno M; Coronel P J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242 [TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia. Gosbell IB; Fernandes LA; Fernandes CJ Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Doern GV; Pfaller MA; Kugler K; Freeman J; Jones RN Clin Infect Dis; 1998 Oct; 27(4):764-70. PubMed ID: 9798031 [TBL] [Abstract][Full Text] [Related]
10. In vitro study on the antimicrobial activity of various antibiotics against clinical isolates of Streptococcus pneumoniae from Belgium collected during winter 1998-1999. Vanhoof R; Carpentier M; Fagnart O; Garrino MG; Glupczynski Y; Gordts B; Govaerts D; Magerman K; Mans Y; Nyssen HJ; Surmont I; Schwam V; Van De Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R Acta Clin Belg; 2000; 55(6):312-22. PubMed ID: 11484422 [TBL] [Abstract][Full Text] [Related]
11. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics. Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995. Doern GV; Heilmann KP; Huynh HK; Rhomberg PR; Coffman SL; Brueggemann AB Antimicrob Agents Chemother; 2001 Jun; 45(6):1721-9. PubMed ID: 11353617 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance of invasive Streptococcus pneumoniae in Slovenia, 1993-1995. The Slovenian Meningitis Study Group. Cizman M; Paragi M; Jovan-Kuhar N; Gubina M; Orazem A; Pokorn M Scand J Infect Dis; 1997; 29(3):251-4. PubMed ID: 9255884 [TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline. Vanhoof R; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Nyssen HJ; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R Acta Clin Belg; 1996; 51(6):377-85. PubMed ID: 8997755 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Doern GV; Brueggemann AB; Pierce G; Hogan T; Holley HP; Rauch A Antimicrob Agents Chemother; 1996 Dec; 40(12):2884-6. PubMed ID: 9124860 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents. Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306 [TBL] [Abstract][Full Text] [Related]
17. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454 [TBL] [Abstract][Full Text] [Related]
18. [Carrier rate of Streptococcus pneumoniae and susceptibility thereof to antimicrobial drugs among children in China: a surveillance study in Beijing, Shanghai, and Guangzhou 2000-2002]. Yao KH; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Shen XZ; Yang YH Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(28):1957-61. PubMed ID: 16313770 [TBL] [Abstract][Full Text] [Related]
19. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014]. Sun H; Chen L; Chen X; Jia X; Li N; Liu W; Tong H; Xiang R; Zhang F; Zhao H; Zhang J; Xu Y Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):30-7. PubMed ID: 26792053 [TBL] [Abstract][Full Text] [Related]
20. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Doern GV; Ferraro MJ; Brueggemann AB; Ruoff KL Antimicrob Agents Chemother; 1996 Apr; 40(4):891-4. PubMed ID: 8849246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]